Protein-Based Biomarkers in Blood Serum Could Classify Individuals With Alzheimer's Disease PDF Print E-mail
9.13.2010 Protein-Based Biomarkers in Blood Serum Could Classify Individuals With Alzheimer's Disease 
Archives of Neurology, JAMA
An initial analysis suggests that biomarkers in blood serum can be combined with clinical information to accurately classify patients with Alzheimer’s disease, according to a report in the September issue of Archives of Neurology, one of the JAMA/Archives journals.
 





Texas Alzheimer’s Research and Care Consortium

TARCC Promotional Video
Watch the TARCC Video Here

Alzheimer's Facts

From 2000-2010, death rates have declined for most major diseases – heart disease (-16 percent), breast cancer (-2 percent), prostate cancer (-8 percent), stroke (-23 percent) and HIV/AIDS (-42 percent) while Alzheimer’s disease deaths rose 68 percent, according to the National Center for Health Statistics.